Nanoncology: A state-of-art update

V. S. Joo, T. G. Ramasamy, R. Murugan, Z. S. Haidar

Research output: Contribution to journalScientific reviewpeer-review

3 Scopus citations

Abstract

Nanoscale drug delivery applications in cancer therapeutics, termed as nanoncology, are being utilized to resolve recurring problems in conventional drug delivery. Nanoparticles have properties unlike their bulk counterparts and the ongoing development of these characteristics continues to increase the repertoire of bio-functionality in regards to interactions of oncotic cellular and molecular systems. Nanoparticles can be constructed in a manner that is tunable and targeted, which gives standard chemotherapy a new approach in terms of drug administration and lowering off-target toxicities. This work concisely discusses pivotal factors in nanoparticle characteristics for cancer therapy providing an up-to-date therapeutics platforms review. Copyright
Original languageAmerican English
Pages (from-to)1-13
Number of pages13
JournalJournal of Bionanoscience
Volume4
Issue number1-2
DOIs
StatePublished - 1 Jun 2010
Externally publishedYes

Keywords

  • Cancer
  • Chemotherapy
  • Drug Delivery
  • Nanobiotechnology
  • Nanoncology
  • Nanoparticle
  • Oncology
  • Polymers
  • Therapy
  • Tumor

Fingerprint Dive into the research topics of 'Nanoncology: A state-of-art update'. Together they form a unique fingerprint.

Cite this